MedPath

A Clinical trial to evaluate the efficacy of Siddha drugs Gandhaga Rasayanam (Internal) & Navanatha sittha thailam (External) in patients having multiple joint pai

Phase 2
Conditions
Health Condition 1: null- Patients having arthritis of three or more joints , Patients having RA factor POSITIVE , morning stiffness, CRP positive and anemia.
Registration Number
CTRI/2017/05/008469
Lead Sponsor
Govt siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1. Patients having arthritis of 3 or more joints

2. Morning stiffness

3. RA factor positive

4. C-Reactive Protein (CRP) positive

5. Anti Cyclic Citrullinated Peptide (Anti CCP) Positive

5. Patients who are willing to undergo laboratory investigations

Exclusion Criteria

1. Rheumatic fever

2. History of sulphur allergy

3. Psoriatic arthropathica,

4. Progressive systemic sclerosis

5. Gouty arthritis,

6. Pregnancy and lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in pain and swelling and morning stiffnessTimepoint: 12months
Secondary Outcome Measures
NameTimeMethod
To study the safety parameters of the drug before and after treatmentTimepoint: 12months
© Copyright 2025. All Rights Reserved by MedPath